Last €33.21 EUR
Change Today +0.59 / 1.79%
Volume 3.5M
GRF On Other Exchanges
Symbol
Exchange
OTC US
OTC US
NASDAQ GS
OTC US
Continuous
Continuous
Frankfurt
Frankfurt
Mexico
As of 11:38 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joel E. Abelson

Corporate Vice President, Chairman of North America Commercial Division -Grifols Inc and President of North America Commercial Division of Grifols Inc, Grifols, S.A.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 3 different industries.

See Board Relationships
55--

Background*

Mr. Joel E. Abelson serves as President of North American Commercial Operations at Grifols USA, LLC. Mr. Abelson has been the Chairman and President of North American Commercial Operations at Grifols, S.A. since June 2011. He oversees the marketing and sales strategy for all of Grifols' North American products. Mr. Abelson served as General Manager of Portfolio Management and International Business and Senior Vice President at Grifols Therapeutics, Inc. (alternate names: ...

Read Full Background

Corporate Headquarters*

Avinguda de la Generalitat, 152-158
Barcelona, Catalonia 08174

Spain

Phone: 34 935 71 22 00
Fax: 34 935 71 02 67

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Master's Degree 1984
University of Toronto
BA 1981
Carleton University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GRF:SM €33.21 EUR +0.59

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$4.3M
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
UCB S.A.
€2.1M
Hartmut Retzlaff Chairman of the Executive Board and Chief Executive Officer of the Executive Board
Stada-Arzneimittel AG
€3.2M
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.0M
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals plc
$2.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GRIFOLS SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.